The collaboration enables customers to safely and securely use AI to accelerate drug research and discovery
BALTIMORE, October 29, 2024–(BUSINESS WIRE)–Sapio Sciences, the science-aware laboratory computing platform, today announced that it has strengthened its long-term relationship with Amazon Web Services, Inc. (AWS) through the integration of AWS Bedrock with the Sapio Platform. This integration makes advanced generative AI models easily accessible to scientists and researchers within the same secure AWS environment that already powers Sapio’s Laboratory Information Management System (LIMS) and Electronic Laboratory Notebook (ELN).
Leveraging Amazon Bedrock’s unique capabilities on the Sapio lab computing platform gives customers access to a variety of the latest AI foundational models, including AI21 Labs, Anthropic and Stability AI. Customers of the Sapio Platform will benefit from leading science-aware tools, including natural language interactions with ELN, integration with AI-powered chatbots, automated generation of experiments from a quick request, and natural language search.
Kevin Cramer, Founder and CEO of Sapio Sciences, commented: “Science-aware AI is specifically designed to simplify the complexities of scientific research and the use of our LIMS and ELN applications. This next generation of AI systems is seamlessly integrated into our laboratory computing platform, empowering scientists to collect, manage and analyze data with unprecedented accuracy”.
Kevin continued: “This collaboration with AWS will allow Sapio customers to accelerate R&D by leveraging the power of natural language interfaces and AI to free up bench time and accelerate the discovery of sustainable solutions. Science-aware AI was enables researchers to focus on high-impact discoveries, driving innovation and breakthroughs in life science research.”
“The work being done in the life sciences and drug discovery industries is some of the most critical research being done today and a perfect environment for AI to deliver real value.” said Ben Schreiner, Chief Innovation Officer for SMB at AWS. “By expanding our long-standing relationship with Sapio Sciences, we’re making science-aware AI available to labs, scientists and researchers in an accessible and unified lab computing platform. We’re excited to see how Sapio’s customers will use this technology to drive the discovery of new and novel solutions to some of the most challenging areas of science being addressed today.”
AWS has been Sapio Sciences’ cloud provider of choice for more than 10 years, with customers using AWS to securely host Sapio’s unified and configurable no-code/low-code lab computing platform.
About Sapio Sciences
Sapio Sciences’ mission is to improve lives by accelerating discovery, and because science is complex, Sapio makes technology simple. Sapio is a global business that provides an all-in-one science-aware laboratory computing platform that combines cloud-based LIMS, ELN and Jarvis data solutions.
Sapio serves some of the largest global and specialty brands, including biopharma, CRO/CDMO and clinical diagnostic laboratories in NGS genomic sequencing, bioanalysis, bioprocessing, chemistry, stability, histopathology and in vivo studies.
Customers love Sapio’s platform because it’s powerful, scalable, and with no-code configuration, it can be quickly adapted to meet unique needs.
For more information, visit www.sapiosciences.com and follow us on LinkedIn.
Check out the source version at businesswire.com: https://www.businesswire.com/news/home/20241029252426/en/
contacts
Zyme Communications
Anna Bakewell
Email: [email protected]
Tim Brook
Head of PR, Sapio Sciences
Tel: +44 (0) 7760 766 213
Email: [email protected]
